Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia

Leslie Citrome, Christoph Correll, Andrew Cutler, Martin Dunbar, Amber Hoberg, Craig Hopkinson, Gregory Mattingly, James McGrory, Bhaskar Rege, Peter Weiden, David McDonnell

Open source

DOI: 10.2147/ndt.s499367
Published: 2025-03
Container: Neuropsychiatric Disease and Treatment
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ndt.s499367,
  title = {Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia},
  author = {Leslie Citrome and Christoph Correll and Andrew Cutler and Martin Dunbar and Amber Hoberg and Craig Hopkinson and Gregory Mattingly and James McGrory and Bhaskar Rege and Peter Weiden and David McDonnell},
  year = {2025},
  journal = {Neuropsychiatric Disease and Treatment},
  doi = {10.2147/ndt.s499367},
  url = {https://doi.org/10.2147/ndt.s499367}
}

RIS

TY  - JOUR
TI  - Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia
AU  - Leslie Citrome
AU  - Christoph Correll
AU  - Andrew Cutler
AU  - Martin Dunbar
AU  - Amber Hoberg
AU  - Craig Hopkinson
AU  - Gregory Mattingly
AU  - James McGrory
AU  - Bhaskar Rege
AU  - Peter Weiden
AU  - David McDonnell
PY  - 2025
JO  - Neuropsychiatric Disease and Treatment
DO  - 10.2147/ndt.s499367
UR  - https://doi.org/10.2147/ndt.s499367
ER  -

APA

Citrome, L., Correll, C., Cutler, A., Dunbar, M., Hoberg, A., Hopkinson, C., Mattingly, G., McGrory, J., Rege, B., Weiden, P., & McDonnell, D. (2025). Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s499367

Source records

crossref · retrieved 2026-09-26T05:00:42.379Z